Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lopes

Showing results (11-20 of 747) with videos related to

Pageof 75
Sort By:
Bioorganic & Medicinal Chemistry|May 20, 2000
Acyloxymethyl as a drug protecting group. Part 6: N-acyloxymethyl- and N-[(aminocarbonyloxy)methyl]sulfonamides as prodrugs of agents containing a secondary sulfonamide groupF Lopes, R Moreira, J Iley
Memorias Do Instituto Oswaldo Cruz|September 16, 2009
The importance of apoptosis for immune regulation in Chagas diseaseGeorge A DosReis, Marcela F Lopes
Pediatric Hematology and Oncology|July 17, 1999
Childhood myelodysplastic syndromes in a Brazilian populationL F Lopes, I Lorand-Metze
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Lipoprotein autoantibodies: measurement and significanceGabriel Virella, Maria F Lopes-Virella
Clinical Immunology and Immunopathology|November 1, 1994
Atherosclerosis and autoimmunityM F Lopes-Virella, G Virella
Frontiers in Endocrinology|June 21, 2012
The Pathogenic Role of the Adaptive Immune Response to Modified LDL in DiabetesGabriel Virella, Maria F Lopes-Virella
Journal of Atherosclerosis and Thrombosis|August 23, 2013
Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosisMaria F Lopes-Virella, Gabriel Virella
Journal of Cellular and Molecular Medicine|December 9, 2009
Imatinib treatment for gastrointestinal stromal tumour (GIST)Lisandro F Lopes, Carlos E Bacchi
Advances in Experimental Medicine and Biology|January 1, 1991
Immune mechanisms in the pathogenesis of atherosclerosisM F Lopes-Virella, G Virella
Current Medicinal Chemistry|May 25, 2018
Modified LDL Immune Complexes and Cardiovascular DiseaseMaria F Lopes-Virella, Gabriel Virella
Pageof 75

Showing results (11-20 of 747) with videos related to

Sort By:
Pageof 75
Bioorganic & Medicinal Chemistry|May 20, 2000
Acyloxymethyl as a drug protecting group. Part 6: N-acyloxymethyl- and N-[(aminocarbonyloxy)methyl]sulfonamides as prodrugs of agents containing a secondary sulfonamide groupF Lopes, R Moreira, J Iley
Memorias Do Instituto Oswaldo Cruz|September 16, 2009
The importance of apoptosis for immune regulation in Chagas diseaseGeorge A DosReis, Marcela F Lopes
Pediatric Hematology and Oncology|July 17, 1999
Childhood myelodysplastic syndromes in a Brazilian populationL F Lopes, I Lorand-Metze
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Lipoprotein autoantibodies: measurement and significanceGabriel Virella, Maria F Lopes-Virella
Clinical Immunology and Immunopathology|November 1, 1994
Atherosclerosis and autoimmunityM F Lopes-Virella, G Virella
Frontiers in Endocrinology|June 21, 2012
The Pathogenic Role of the Adaptive Immune Response to Modified LDL in DiabetesGabriel Virella, Maria F Lopes-Virella
Journal of Atherosclerosis and Thrombosis|August 23, 2013
Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosisMaria F Lopes-Virella, Gabriel Virella
Journal of Cellular and Molecular Medicine|December 9, 2009
Imatinib treatment for gastrointestinal stromal tumour (GIST)Lisandro F Lopes, Carlos E Bacchi
Advances in Experimental Medicine and Biology|January 1, 1991
Immune mechanisms in the pathogenesis of atherosclerosisM F Lopes-Virella, G Virella
Current Medicinal Chemistry|May 25, 2018
Modified LDL Immune Complexes and Cardiovascular DiseaseMaria F Lopes-Virella, Gabriel Virella
Pageof 75